- Home
- MPTI vs MAIA Comparison
MPTI vs MAIA Comparison
Compare MPTI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- MAIA
- Stock Information
- Founded
- MPTI 1965
- MAIA 2018
- Country
- MPTI United States
- MAIA United States
- Employees
- MPTI N/A
- MAIA N/A
- Industry
- MPTI
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- MPTI
- MAIA Health Care
- Exchange
- MPTI Nasdaq
- MAIA Nasdaq
- Market Cap
- MPTI 136.1M
- MAIA 46.7M
- IPO Year
- MPTI N/A
- MAIA 2022
- Fundamental
- Price
- MPTI $40.26
- MAIA $1.82
- Analyst Decision
- MPTI
- MAIA
- Analyst Count
- MPTI 0
- MAIA 0
- Target Price
- MPTI N/A
- MAIA N/A
- AVG Volume (30 Days)
- MPTI 89.7K
- MAIA 549.7K
- Earning Date
- MPTI 08-13-2025
- MAIA 08-08-2025
- Dividend Yield
- MPTI N/A
- MAIA N/A
- EPS Growth
- MPTI 66.11
- MAIA N/A
- EPS
- MPTI 2.67
- MAIA N/A
- Revenue
- MPTI $50,559,000.00
- MAIA N/A
- Revenue This Year
- MPTI $11.76
- MAIA N/A
- Revenue Next Year
- MPTI $7.64
- MAIA N/A
- P/E Ratio
- MPTI $15.05
- MAIA N/A
- Revenue Growth
- MPTI 17.62
- MAIA N/A
- 52 Week Low
- MPTI $23.93
- MAIA $1.40
- 52 Week High
- MPTI $60.00
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- MPTI 39.72
- MAIA 53.36
- Support Level
- MPTI $39.02
- MAIA $1.60
- Resistance Level
- MPTI $42.70
- MAIA $2.03
- Average True Range (ATR)
- MPTI 3.11
- MAIA 0.12
- MACD
- MPTI 0.00
- MAIA 0.02
- Stochastic Oscillator
- MPTI 30.94
- MAIA 58.14
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.